These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 23582604)

  • 1. [Brachytherapy for anal cancers].
    Pommier P; Mirabel X; Hannoun-Lévi JM; Malet C; Gérard JP; Peiffert D
    Cancer Radiother; 2013 Apr; 17(2):143-50. PubMed ID: 23582604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experience with split-course external beam irradiation +/- chemotherapy and integrated Ir-192 high-dose-rate brachytherapy in the treatment of primary carcinomas of the anal canal.
    Kapp KS; Geyer E; Gebhart FH; Oechs AC; Berger A; Hebenstreit J; Stoeger H
    Int J Radiat Oncol Biol Phys; 2001 Mar; 49(4):997-1005. PubMed ID: 11240240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Epidermoid carcinomas of anal canal treated with radiation therapy and concomitant chemotherapy (5-fluorouracil and cisplatin)].
    Deniaud-Alexandre E; Touboul E; Tiret E; Sezeur A; Hannoun L; Houry S; Huguet F; Pène F; Parc R; Schlienger M
    Cancer Radiother; 2006 Dec; 10(8):572-82. PubMed ID: 17110148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemoradiotherapy with Brachytherapy or Electron Therapy Boost for Locally Advanced Squamous Cell Carcinoma of the Anus-Reducing the Colostomy Rate.
    Kent C; Bessell EM; Scholefield JH; Chappell S; Marsh L; Mills J; Sayers I
    J Gastrointest Cancer; 2017 Mar; 48(1):1-7. PubMed ID: 27412395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Epidermoid carcinomas of the anal canal treated with definitive radiation therapy in a series of 305 patients].
    Deniaud-Alexandre E; Touboul E; Tiret E; Sezeur A; Houry S; Gallot D; Parc R; Huang R; Qu SH; Pène F; Schlienger M
    Cancer Radiother; 2003 Aug; 7(4):237-53. PubMed ID: 12914857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Management of locally advanced anal canal carcinoma with modulated arctherapy and concurrent chemotherapy].
    Troussier I; Huguet F; Servagi-Vernat S; Benahim C; Khalifa J; Darmon I; Ortholan C; Krebs L; Dejean C; Fenoglietto P; Vieillot S; Bensadoun RJ; Thariat J
    Cancer Radiother; 2015 Apr; 19(2):127-38. PubMed ID: 25770884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interstitial hyperthermia and high dose rate brachytherapy in the treatment of anal cancer: a phase I/II study.
    Kapp KS; Kapp DS; Stuecklschweiger G; Berger A; Geyer E
    Int J Radiat Oncol Biol Phys; 1994 Jan; 28(1):189-99. PubMed ID: 8270441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-dose-rate interstitial brachytherapy boost for the treatment of anal canal cancers.
    Cordoba A; Escande A; Leroy T; Mirabel X; Coche-Dequéant B; Lartigau E
    Brachytherapy; 2017; 16(1):230-235. PubMed ID: 27600606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of the Primary Tumor in Anal Canal Cancers.
    Glynne-Jones R; Rao S
    Surg Oncol Clin N Am; 2017 Jan; 26(1):73-90. PubMed ID: 27889038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of squamous cell anal canal carcinoma with pulsed dose rate brachytherapy. Feasibility study of a French cooperative group.
    Gerard JP; Mauro F; Thomas L; Castelain B; Mazeron JJ; Ardiet JM; Peiffert D
    Radiother Oncol; 1999 May; 51(2):129-31. PubMed ID: 10435803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of anal canal carcinoma with high dose radiation therapy and concomitant fluorouracil-cisplatinum. Long-term results in 95 patients.
    Gerard JP; Ayzac L; Hun D; Romestaing P; Coquard R; Ardiet JM; Mornex F
    Radiother Oncol; 1998 Mar; 46(3):249-56. PubMed ID: 9572617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Rationale and progress of the phase III trial: intensification of the treatment of locally advanced squamous cell carcinoma of the anal canal].
    Peiffert D
    Cancer Radiother; 2003 Nov; 7 Suppl 1():100s-107s. PubMed ID: 15124551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concomitant chemoradiotherapy with Cisplatin plus 5-Fluorouracil for anal squamous cell carcinoma.
    El-Hadaad HA; Wahba HA; Roshdy S
    J Gastrointest Cancer; 2015 Jun; 46(2):156-60. PubMed ID: 25810165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "Mind the gap"--the impact of variations in the duration of the treatment gap and overall treatment time in the first UK Anal Cancer Trial (ACT I).
    Glynne-Jones R; Sebag-Montefiore D; Adams R; McDonald A; Gollins S; James R; Northover JM; Meadows HM; Jitlal M;
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1488-94. PubMed ID: 20934265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Definitive radiotherapy based on HDR brachytherapy with iridium 192 in uterine cervix carcinoma: report on the Vienna University Hospital findings (1993-1997) compared to the preceding period in the context of ICRU 38 recommendations.
    Pötter R; Knocke TH; Fellner C; Baldass M; Reinthaller A; Kucera H
    Cancer Radiother; 2000; 4(2):159-72. PubMed ID: 10812362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2 × 2 factorial trial.
    James RD; Glynne-Jones R; Meadows HM; Cunningham D; Myint AS; Saunders MP; Maughan T; McDonald A; Essapen S; Leslie M; Falk S; Wilson C; Gollins S; Begum R; Ledermann J; Kadalayil L; Sebag-Montefiore D
    Lancet Oncol; 2013 May; 14(6):516-24. PubMed ID: 23578724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of anal carcinoma in the elderly: feasibility and outcome of radical radiotherapy with or without concomitant chemotherapy.
    Allal AS; Obradovic M; Laurencet F; Roth AD; Spada A; Marti MC; Kurtz JM
    Cancer; 1999 Jan; 85(1):26-31. PubMed ID: 9921970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interstitial pulsed-dose-rate brachytherapy for the treatment of squamous cell anal carcinoma: A retrospective single institution analysis.
    Boukhelif W; Ferri-Molina M; Mazeron R; Maroun P; Duhamel-Oberlander AS; Dumas I; Martinetti F; Guemnie-Tafo A; Chargari C; Haie-Meder C
    Brachytherapy; 2015; 14(4):549-53. PubMed ID: 25935731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose escalation in chemoradiation for anal cancer: preliminary results of RTOG 92-08.
    John M; Pajak T; Flam M; Hoffman J; Markoe A; Wolkov H; Paris K
    Cancer J Sci Am; 1996; 2(4):205-11. PubMed ID: 9166533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a 36 Gy elective node irradiation dose in anal cancer.
    Lépinoy A; Lescut N; Puyraveau M; Caubet M; Boustani J; Lakkis Z; Fantoli M; Buffet-Miny J; Kim S; Bednarek C; Maingon P; Créhange G; Bosset JF
    Radiother Oncol; 2015 Aug; 116(2):197-201. PubMed ID: 26277433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.